🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
Last 7 Days
›
Biotechnology Industry
Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(28)
All (246)
Buys (28)
Sells (218)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
Grace Therapeutics, Inc.
(GRCE)
Opaleye Management Inc.
— 10% Owner
Oct 5, 2026
Purchase
Shares
1,694
Price
$2.06
Total Value
$3.49K
Shares Held After
2,858,657
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
InMed Pharmaceuticals Inc.
(INM)
ADAR1 Capital Management, LLC
— 10% Owner
Oct 5, 2026
Purchase
Shares
18,182
Price
$1.33
Total Value
$24.18K
Shares Held After
935,021
% of Holdings
1.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Grace Therapeutics, Inc.
(GRCE)
Opaleye Management Inc.
— 10% Owner
Oct 2, 2026
Purchase
Shares
20,000
Price
$2.07
Total Value
$41.37K
Shares Held After
2,856,963
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
InMed Pharmaceuticals Inc.
(INM)
ADAR1 Capital Management, LLC
— 10% Owner
Oct 2, 2026
Purchase
Shares
8,307
Price
$1.33
Total Value
$11.05K
Shares Held After
916,839
% of Holdings
0.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PALISADE BIO, INC.
(PALI)
Williams Donald Allen
— Director
Oct 2, 2026
Purchase
Shares
10,000
Price
$1.46
Total Value
$14.60K
Shares Held After
1,590,294
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Grace Therapeutics, Inc.
(GRCE)
Opaleye Management Inc.
— 10% Owner
Oct 1, 2026
Purchase
Shares
38,796
Price
$2.04
Total Value
$78.96K
Shares Held After
2,836,963
% of Holdings
1.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
InMed Pharmaceuticals Inc.
(INM)
ADAR1 Capital Management, LLC
— 10% Owner
Oct 1, 2026
Purchase
Shares
16,431
Price
$1.33
Total Value
$21.85K
Shares Held After
908,532
% of Holdings
1.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PALISADE BIO, INC.
(PALI)
Williams Donald Allen
— Director
Oct 1, 2026
Purchase
Shares
10,000
Price
$1.42
Total Value
$14.20K
Shares Held After
1,580,294
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Compass Therapeutics, Inc.
(CMPX)
Lerner Neil
— Chief Accounting Officer
Oct 1, 2026
Purchase
Shares
20,000
Price
$0.92
Total Value
$18.40K
Shares Held After
420,000
% of Holdings
4.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Lipocine Inc.
(LPCN)
Higuchi John W.
— Director
Sep 30, 2026
Purchase
Shares
15,970
Price
$2.23
Total Value
$35.61K
Shares Held After
241,365
% of Holdings
6.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Xenon Pharmaceuticals Inc.
(XENE)
MORTIMER IAN
— Director
Sep 30, 2026
Purchase
Shares
30,000
Price
$37.38
Total Value
$1.12M
Shares Held After
49,923
% of Holdings
60.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Xenon Pharmaceuticals Inc.
(XENE)
Kelly Thomas Patrick
— Chief Financial Officer
Sep 30, 2026
Purchase
Shares
15,000
Price
$37.32
Total Value
$559.74K
Shares Held After
15,000
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
FILANA THERAPEUTICS, INC.
(FLNA)
Barry Richard
— Director
Sep 30, 2026
Purchase
Shares
100,000
Price
$0.92
Total Value
$92.00K
Shares Held After
1,337,964
% of Holdings
7.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Anixa Biosciences Inc
(ANIX)
Catelani Michael
— President, COO,&CFO
Sep 30, 2026
Purchase
Shares
5,500
Price
$2.84
Total Value
$15.62K
Shares Held After
50,000
% of Holdings
11.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Hepion Pharmaceuticals, Inc.
(HEPA)
Fisher Danina
— Director
Sep 29, 2026
Purchase
Shares
200,000
Price
$0.05
Total Value
$10.00K
Shares Held After
200,000
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Helus Pharma Inc.
(HELP)
Cavers Greg
— Chief Financial Officer
Sep 29, 2026
Purchase
Shares
3,000
Price
$12.91
Total Value
$38.73K
Shares Held After
3,000
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Lipocine Inc.
(LPCN)
Higuchi John W.
— Director
Sep 29, 2026
Purchase
Shares
9,037
Price
$2.15
Total Value
$19.43K
Shares Held After
225,395
% of Holdings
4.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Grace Therapeutics, Inc.
(GRCE)
Opaleye Management Inc.
— 10% Owner
Sep 29, 2026
Purchase
Shares
7,849
Price
$2.09
Total Value
$16.40K
Shares Held After
2,798,167
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
FILANA THERAPEUTICS, INC.
(FLNA)
Barry Richard
— Director
Sep 29, 2026
Purchase
Shares
206,813
Price
$0.90
Total Value
$186.13K
Shares Held After
1,237,964
% of Holdings
16.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BioCardia, Inc.
(BCDA)
Altman Peter
— Director
Sep 29, 2026
Purchase
Shares
1,000
Price
$1.03
Total Value
$1.03K
Shares Held After
384,885
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PROTHENA CORP PUBLIC LTD CO
(PRTA)
SCULLY WILLIAM P
— 10% Owner
Sep 29, 2026
Purchase
Shares
162,000
Price
$8.68
Total Value
$1.41M
Shares Held After
214,000
% of Holdings
75.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Kodiak Sciences Inc.
(KOD)
BAKER BROS. ADVISORS LP
— Director
Sep 29, 2026
Purchase
Shares
1,416
Price
$85.89
Total Value
$121.61K
Shares Held After
20,191,214
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Kodiak Sciences Inc.
(KOD)
BAKER BROS. ADVISORS LP
— Director
Sep 29, 2026
Purchase
Shares
84
Price
$85.89
Total Value
$7.21K
Shares Held After
1,669,727
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Kodiak Sciences Inc.
(KOD)
BAKER BROS. ADVISORS LP
— Director
Sep 29, 2026
Purchase
Shares
20,031
Price
$85.40
Total Value
$1.71M
Shares Held After
20,189,798
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Kodiak Sciences Inc.
(KOD)
BAKER BROS. ADVISORS LP
— Director
Sep 29, 2026
Purchase
Shares
1,195
Price
$85.40
Total Value
$102.06K
Shares Held After
1,669,643
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Kodiak Sciences Inc.
(KOD)
BAKER BROS. ADVISORS LP
— Director
Sep 29, 2026
Purchase
Shares
10,381
Price
$84.24
Total Value
$874.52K
Shares Held After
20,169,767
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Kodiak Sciences Inc.
(KOD)
BAKER BROS. ADVISORS LP
— Director
Sep 29, 2026
Purchase
Shares
619
Price
$84.24
Total Value
$52.15K
Shares Held After
1,668,448
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Phio Pharmaceuticals Corp.
(PHIO)
Plott Ronald Todd
— Director
Sep 29, 2026
Purchase
Shares
5,000
Price
$1.04
Total Value
$5.20K
Shares Held After
42,000
% of Holdings
11.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Showing 1–28 of 28 transactions (page 1 of 1)
Version: v26.10.4